Related Experiment Video
Updated: Aug 30, 2025
Determining Bile Duct Density in the Mouse Liver
Published on: April 30, 2019
Arid1a mutation suppresses TGF-β signaling and induces cholangiocarcinoma
Bing Guo1, Scott C Friedland2, William Alexander2
1Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA; Division of Hematology and Oncology, Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, 300 Elmwood Avenue, Rochester, NY 14642, USA.
Abstract:
Activating KRAS mutations and functional loss of members of the SWI/SNF complex, including ARID1A, are found together in the primary liver tumor cholangiocarcinoma (CC). How these mutations cooperate to promote CC has not been established. Using murine models of hepatocyte and biliary-specific lineage tracing, we show that Kras and Arid1a mutations drive the formation of CC and tumor precursors from the biliary compartment, which are accelerated by liver inflammation. Using cultured cells, we find that Arid1a loss causes cellular proliferation, escape from cell-cycle control, senescence, and widespread changes in chromatin structure. Notably, we show that the biliary proliferative response elicited by Kras/Arid1a cooperation and tissue injury in CC is caused by failed engagement of the TGF-β-Smad4 tumor suppressor pathway. We thus identify an ARID1A-TGF-β-Smad4 axis as essential in limiting the biliary epithelial response to oncogenic insults, while its loss leads to biliary pre-neoplasia and CC.
Insights
Activating KRAS mutations and ARID1A loss drive cholangiocarcinoma (CC) formation in mice. This occurs via failed TGF-β-Smad4 signaling, revealing a crucial pathway in liver cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Activating KRAS mutations and ARID1A loss are co-occurring in cholangiocarcinoma (CC).
- The cooperative mechanisms driving CC by these mutations remain unclear.
Purpose of the Study:
- To investigate how KRAS and ARID1A mutations cooperate to promote CC.
- To elucidate the molecular pathways involved in CC development.
Main Methods:
- Utilized murine models with hepatocyte and biliary-specific lineage tracing.
- Employed cultured cells to study cellular responses to genetic alterations.
- Investigated the role of the TGF-β-Smad4 pathway.
Main Results:
- Kras and Arid1a mutations induce CC and precursor lesions from the biliary compartment, accelerated by inflammation.
- ARID1A loss promotes cellular proliferation, cell-cycle escape, senescence, and chromatin alterations.
- Kras/Arid1a cooperation in CC involves failed engagement of the TGF-β-Smad4 tumor suppressor pathway.
Conclusions:
- Identified an ARID1A-TGF-β-Smad4 axis critical for limiting biliary epithelial response to oncogenic insults.
- Loss of this axis leads to biliary pre-neoplasia and CC development.
Related Concept Videos
01:16TGF - β Signaling Pathway
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:23Abnormal Proliferation
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...